Invention Grant
- Patent Title: Artifical nucleases comprising engineered cleavage half-domains
-
Application No.: US16838804Application Date: 2020-04-02
-
Publication No.: US11136599B2Publication Date: 2021-10-05
- Inventor: Yannick Doyon , Jeffrey C. Miller
- Applicant: Sangamo Therapeutics, Inc.
- Applicant Address: US CA Richmond
- Assignee: Sangamo Therapeutics, Inc.
- Current Assignee: Sangamo Therapeutics, Inc.
- Current Assignee Address: US CA Richmond
- Agency: Foley & Lardner LLP
- Main IPC: C12N15/90
- IPC: C12N15/90 ; C12N9/22 ; C12N15/85 ; C07K14/47 ; C07K7/06

Abstract:
Disclosed herein are engineered cleavage half-domains; fusion polypeptides comprising these engineered cleavage half-domains; polynucleotides encoding the engineered cleavage half-domains and fusion proteins; and cells comprising said polynucleotides and/or fusion proteins. Also described are methods of using these polypeptides and polynucleotides, for example for targeted cleavage of a genomic sequence.
Public/Granted literature
- US20200231988A1 ENGINEERED CLEAVAGE HALF-DOMAINS Public/Granted day:2020-07-23
Information query
IPC分类: